SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director at Guardant Health has filed a notice of proposed sale for a nominal amount of stock, valued at approximately $11,769, under a pre-arranged 10b5-1 trading plan.
• Market Impact: The transaction is immaterial and is expected to have no impact on the stock price or market sentiment.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH (Inferred)
CIK	0001576280
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Tariq Musa
CIK	0001968281
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	144 (Notice of Proposed Sale)
Transaction Date	2025-12-17 (Approximate)
Transaction Code	Not Applicable
Security Type	Common Stock
Shares Involved	116
Price Per Share	~$101.46 (Calculated)
Total Value	$11,769.00
Shares Owned After	Not Disclosed
Ownership Type	Not Disclosed

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$11,769.00
% of Market Cap	0.000096%
Shares Transacted	116
% of Shares Outstanding	0.000092%
Post-Transaction Ownership	Not Disclosed
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $12.26 billion, this $11.8k transaction is financially insignificant.
• Ownership Concentration: The number of shares being sold is negligible compared to the 126,041,089 shares outstanding, indicating no change in ownership influence.
• Transaction Significance: The sale represents a minuscule fraction of both the company's market value and its total shares. Based on materiality thresholds, this transaction is rated as Low significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is extremely small and was executed under a 10b5-1 plan adopted on September 11, 2024. Such pre-planned, minor sales are routine for insiders for personal financial management and do not signal any change in their outlook on the company.

Volume & Sentiment

• Expected Volume Impact: None. The trade size is too small to affect trading volume.
• Sentiment Indicator: Neutral. The market will likely disregard this filing due to its immaterial nature.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates this proposed sale is pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined schedule for selling stocks at a future date. This removes the implication that the sale is based on any non-public information.
• Pattern of Sales: The filing also discloses similar small sales in the preceding three months, reinforcing the routine and automated nature of these transactions.